GRT US Holding, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$16.3M
Doctors Paid
10,200
Transactions
28,935
2024 Total
$39,958
Payment Breakdown by Category
Research$12.0M (73.8%)
Consulting$1.4M (8.5%)
Travel$811,441 (5.0%)
Food & Beverage$662,114 (4.1%)
Royalty/License$13,888 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $12.0M | 2,206 | 73.8% |
| Consulting Fee | $1.4M | 253 | 8.5% |
| Honoraria | $1.2M | 488 | 7.2% |
| Travel and Lodging | $811,441 | 1,645 | 5.0% |
| Food and Beverage | $662,114 | 24,224 | 4.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $208,629 | 77 | 1.3% |
| Royalty or License | $13,888 | 6 | 0.1% |
| Grant | $3,000 | 1 | 0.0% |
| Education | $1,525 | 35 | 0.0% |
Payments by Type
Research
$12.0M
2,206 transactions
General
$4.3M
26,729 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A SINGLE INTRAARTICULAR INJECTION OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $6.3M | 0 | 1,323 |
| KF7013-04 | $1.6M | 3 | 295 |
| KF7013-02 | $1.4M | 5 | 348 |
| PSNP | $1.1M | 0 | 4 |
| PSMP | $636,282 | 0 | 2 |
| AV001 | $430,482 | 0 | 169 |
| A SINGLEARM OPENLABEL PHASE III TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN SUBJECTS WITH MODERATE TO SEVERE PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $350,568 | 0 | 42 |
| A RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF INTRAARTICULAR INJECTIONS OF RTXGRT7039 IN ADULT SUBJECTS WITH PAIN ASSOCIATED WITH OSTEOARTHRITIS OF THE KNEE | $175,533 | 0 | 20 |
| Surgery Registry Study | $7,591 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Ms. Kiran Patel, Md, Daba, Dapm, MD, DABA, DAPM | Anesthesiology | New York, NY | $30,479 | $0 |
| Dr. Michael King, Dpm, DPM | Podiatrist | Nashville, TN | $29,445 | $0 |
| Oscar De Leon, Md, MD | Pain Medicine | Buffalo, NY | $27,558 | $0 |
| Dr. Maged Guirguis, M.d, M.D | Pain Medicine | New Orleans, LA | $25,787 | $0 |
| Carl Hauser, M.d, M.D | Surgical Critical Care | Sonora, CA | $25,680 | $0 |
| Rodica Busui, Md, Phd, MD, PHD | Endocrinology, Diabetes & Metabolism | Portland, OR | $24,889 | $0 |
| Daniel Pak, M.d, M.D | Anesthesiology | Houston, TX | $24,825 | $0 |
| Roy Freeman, M.d, M.D | Neurology | Boston, MA | $24,454 | $0 |
| Gary Graf, Aprn, APRN | Nurse Practitioner | Topeka, KS | $21,711 | $0 |
| Morgan Jones, Md, MD | Orthopaedic Surgery | Boston, MA | $21,293 | $0 |
| Dr. Hersh Patel, Md, Mba, MD, MBA | Anesthesiology | Newark, DE | $19,920 | $0 |
| Atul Patel, M.d, M.D | Physical Medicine & Rehabilitation | Overland Park, KS | $18,406 | $0 |
| Jessica Oswald, Md, MD | Pain Medicine | San Diego, CA | $18,259 | $0 |
| Dr. Romanth Waghmarae | Anesthesiology | Hamburg, NY | $17,941 | $0 |
| Orlando Landrum, Md, MD | Pain Medicine | Elkhart, IN | $17,662 | $0 |
| Dr. David Glick, M.d, M.D | Family Medicine | Saint Louis, MO | $17,375 | $0 |
| Shannon Gregg, Aprn, APRN | Nurse Practitioner | Topeka, KS | $16,973 | $0 |
| Kim Huynh, Acagnp & Fnp, ACAGNP & FNP | Neurology | Cypress, TX | $16,836 | $0 |
| Dr. Sean Li, M.d, M.D | Pain Medicine | Shrewsbury, NJ | $15,196 | $0 |
| Dr. Michele Askar, D.c, D.C | Chiropractor | Monaca, PA | $15,055 | $0 |
| Jeffrey Gudin, Md, MD | Hospice and Palliative Medicine | Miami, FL | $14,619 | $0 |
| Mrs. Jodi Kahan, Fnp, FNP | Family | Newark, DE | $14,604 | $0 |
| Theresa Mallick-Searle, N.p, N.P | Nurse Practitioner | Stanford, CA | $12,942 | $0 |
| Asokumar Buvanendran | Anesthesiology | Chicago, IL | $12,716 | $0 |
| John Peppin, D.o, D.O | Internal Medicine | Cynthiana, KY | $12,711 | $0 |
Ad
Top Products
- Qutenza $5.7M
- Neridronic acid $2.7M
Associated Products (4)
- Qutenza $5.7M
- Neridronic acid $2.7M
- Nerizonate $290,129
- Cutis $13,262
Payment Categories
- Food & Beverage $662,114
- Consulting $1.4M
- Travel & Lodging $811,441
- Research $12.0M
- Royalties $13,888
About GRT US Holding, Inc.
GRT US Holding, Inc. has made $16.3M in payments to 10,200 healthcare providers, recorded across 28,935 transactions in the CMS Open Payments database. In 2024, the company paid $39,958. The top product by payment volume is Qutenza ($5.7M).
Payments were distributed across 167 medical specialties. The top specialty by payment amount is Pain Medicine ($910,294 to 837 doctors).
Payment categories include: Food & Beverage ($662,114), Consulting ($1.4M), Research ($12.0M), Travel & Lodging ($811,441), Royalties ($13,888).
GRT US Holding, Inc. is associated with 4 products in the CMS Open Payments database, including Qutenza, Neridronic acid, and Nerizonate.